JNB Healthcare Medical - Pharmaceuticals DCP.JO

Dis-Chem Pharmacies Limited

$ 3 412.00 3.90 %

Dis-Chem Pharmacies Limited (DCP.JO) is a leading South African enterprise engaged in both the retail and wholesale supply of healthcare products and pharmaceuticals. The company operates through two distinct segments: Retail and Wholesale. Its extensive retail network encompasses numerous stores that provide a wide array of offerings, including dispensary services, personal care and beauty products, health and nutrition items, and baby essentials. These outlets further enhance their customer experience by offering ancillary services like healthcare clinics and hair and beauty salons. Dis-Chem also maintains an online platform that facilitates convenient click & collect services for its customers. On the wholesale front, the company handles the distribution of pharmaceutical, health, and general front-shop products, delivers specialized pharma-logistic solutions, and manages customer loyalty initiatives. Established in 1978 and headquartered in Midrand, South Africa, Dis-Chem boasts a substantial presence with 289 stores spread across all nine South African provinces, supplemented by four outlets in Namibia and two in Botswana.

CEO: Rui Manuel Morais - https://dischemgroup.com

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ 4 643.65

Loading data...

DCP.JO vs S&P500

Loading data...

No data available.

Quick ratio

0.40

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

29.93

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

1.14

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

17.37 %

reflects reasonable profitability, showing good use of equity.

ROIC

11.05 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

5.90

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

1.18

means it relies more on debt, which can increase financial risk.

Free cash flow per share

1.42

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

53.55 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
6.13 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.04 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.32 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.